NCT03178942 - Multiple-Site Study to Evaluate the Therapeutic Equivalence of Permethrin Cream, 5% in the Treatment of Scabies | Biotech Hunter

Enrollment

254

Participants

Timeline

Start Date

June 1, 2017

Primary Completion Date

November 11, 2017

Study Completion Date

November 11, 2017

Conditions

Scabies

Interventions

DRUG

Permethrin Cream, 5%

Permethrin Cream 5%

DRUG

Elimite™ Cream (permethrin) 5%

Permethrin Cream 5%

Trial Locations (15)

18201

DermDox Cetners for Dermatology, Hazleton

33015

Integrity Clinical Research Center, Inc., Hialeah

33172

Lenus Research & Medical Group, LLC, Sweetwater

34744

The Chappel Group Research, Kissimmee

72212

Applied Research Center of Arkansas, Little Rock

77055

West Houston Clinical Research Services, Houston

78215

Sun Research Instiute, San Antonio

90806

Long Beach Clinical Trials, Long Beach

91105

Havana Research Institute, Pasadena

92804

St. Josephs Clinical Research, Anaheim

O1101

Clinica Dermatologica/APF Research International, San Salvador

O1501

Clinica Dermatologica Y Cirugia de Piel/APF Research International, San Salvador

Unknown

Clinica de la Doctora Laura Vargas, San Salvador

OO703

APF Research International, Aguas Buenas

OO772

APF Research International, Loíza